Healthcare - Biotechnology - NASDAQ - US
$ 3.19
0.315 %
$ 130 M
Market Cap
-1.54
P/E
INCOME STATEMENT
0
REVENUE
-88.9 M
OPERATING INCOME
-82.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Vigil Neuroscience, Inc.
| Revenue | 0 |
| Cost Of Revenue | 399 K |
| Gross Profit | -399 K |
| Operating Expenses | 88.9 M |
| Operating Income | -88.9 M |
| Other Expenses | -6.23 M |
| Net Income | -82.6 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0.4 | 1.0 | 0.3 | 0 |
| Gross Profit | (0.4) | (1.0) | (0.3) | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 88.9 | 68.9 | 42.4 | 6.3 |
| Selling, General and Administrative Expenses | 27.9 | 21.4 | 10.1 | 1.8 |
| Research and Development Expenses | 60.9 | 47.4 | 32.3 | 4.5 |
| Operating Income | (88.9) | (68.9) | (42.4) | (6.3) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 78 K | 0 | 0 |
| Total Other Income | 6.2 | 0.6 | (0.9) | (22.3) |
| Pre-Tax Income | (82.6) | (68.3) | (43.3) | (28.5) |
| NET INCOME | ||||
| Tax Provision | 0 | (0.6) | 31 K | 12.6 K |
| Net Income | (82.6) | (67.7) | (43.3) | (28.5) |
| EPS | 2.13 | 2.14 | 28.2 | 1.01 |